Viral determinants of HIV-1 macrophage tropism

Viruses

Volumn 3, Issue 11, 2011, Pages 2255-2279

  Duncan, Christopher J A ^a   Sattentau, Quentin J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Evolution; HIV 1; Macrophage; Monocyte; Transmitted founder virus; Tropism

Indexed keywords

CD4 ANTIGEN; ENVELOPE PROTEIN; NEF PROTEIN; PROTEIN VPX; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS PROTEIN; VPR PROTEIN; VPU PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; NONHUMAN; PATHOGENESIS; RECEPTOR BINDING; VIRAL TROPISM; VIRUS ISOLATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, CD4; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; RECEPTORS, VIRUS; VIRAL TROPISM;

EID: 82155197617     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3112255     Document Type: Article

References (160)

1. Gordon, S.; Martinez, F.O. Alternative activation of macrophages: Mechanism and functions. Immunity 2010, 32, 593-604.
2. Murray, P.J.; Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11, 723-737.
3. Gras, G.; Kaul, M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 2010, 7, 30.
4. Coiras, M.; Lopez-Huertas, M.R.; Perez-Olmeda, M.; Alcami, J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat. Rev. Microbiol. 2009, 7, 798-812.
5. Gousset, K.; Ablan, S.D.; Coren, L.V.; Ono, A.; Soheilian, F.; Nagashima, K.; Ott, D.E.; Freed, E.O. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 2008, 4, e1000015.
6. Groot, F.; Welsch, S.; Sattentau, Q.J. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 2008, 111, 4660-4663.
7. Goodenow, M.M.; Rose, S.L.; Tuttle, D.L.; Sleasman, J.W. HIV-1 fitness and macrophages. J. Leukoc. Biol. 2003, 74, 657-666.
8. Gorry, P.R.; Ancuta, P. Coreceptors and HIV-1 pathogenesis. Curr. HIV AIDS Rep. 2011, 8, 45-53.
9. Ugolini, S.; Mondor, I.; Sattentau, Q.J. HIV-1 attachment: Another look. Trends Microbiol. 1999, 7, 144-149.
10. Ballana, E.; Pauls, E.; Senserrich, J.; Clotet, B.; Perron-Sierra, F.; Tucker, G.C.; Este, J.A. Cell adhesion through alphaV-containing integrins is required for efficient HIV-1 infection in macrophages. Blood 2009, 113, 1278-1286.
11. Saphire, A.C.; Bobardt, M.D.; Zhang, Z.; David, G.; Gallay, P.A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 2001, 75, 9187-9200.
12. Mercer, J.; Helenius, A. Virus entry by macropinocytosis. Nat. Cell Biol. 2009, 11, 510-520.
13. Miyauchi, K.; Kim, Y.; Latinovic, O.; Morozov, V.; Melikyan, G.B. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137, 433-444.
14. Gray, L.; Sterjovski, J.; Churchill, M.; Ellery, P.; Nasr, N.; Lewin, S.R.; Crowe, S.M.; Wesselingh, S.L.; Cunningham, A.L.; Gorry, P.R. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 2005, 337, 384-398.
15. Peters, P.J.; Sullivan, W.M.; Duenas-Decamp, M.J.; Bhattacharya, J.; Ankghuambom, C.; Brown, R.; Luzuriaga, K.; Bell, J.; Simmonds, P.; Ball, J. et al. Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: Implications for transmission and pathogenesis. J. Virol. 2006, 80, 6324-6332.
16. Keele, B.F. Identifying and characterizing recently transmitted viruses. Curr. Opin. HIV AIDS 2010, 5, 327-334.
17. Keele, B.F.; Giorgi, E.E.; Salazar-Gonzalez, J.F.; Decker, J.M.; Pham, K.T.; Salazar, M.G.; Sun, C.; Grayson, T.; Wang, S.; Li, H. et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 7552-7557.
18. Xu, Y.; Zhu, H.; Wilcox, C.K.; van't Wout, A.; Andrus, T.; Llewellyn, N.; Stamatatos, L.; Mullins, J.I.; Corey, L.; Zhu, T. Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus. J. Infect. Dis. 2008, 197, 309-318.
19. Koenig, S.; Gendelman, H.E.; Orenstein, J.M.; Dal Canto, M.C.; Pezeshkpour, G.H.; Yungbluth, M.; Janotta, F.; Aksamit, A.; Martin, M.A.; Fauci, A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986, 233, 1089-1093.
20. Smith, P.D.; Fox, C.H.; Masur, H.; Winter, H.S.; Alling, D.W. Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J. Exp. Med. 1994, 180, 1541-1546.
21. Lewin, S.R.; Kirihara, J.; Sonza, S.; Irving, L.; Mills, J.; Crowe, S.M. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 1998, 12, 719-727.
22. Bergamaschi, A.; Pancino, G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010, 7, 31.
23. Coleman, C.M.; Wu, L. HIV interactions with monocytes and dendritic cells: Viral latency and reservoirs. Retrovirology 2009, 6, 51.
24. Goodenow, M.M.; Collman, R.G. HIV-1 coreceptor preference is distinct from target cell tropism: A dual-parameter nomenclature to define viral phenotypes. J. Leukoc. Biol. 2006, 80, 965-972.
25. Jayakumar, P.; Berger, I.; Autschbach, F.; Weinstein, M.; Funke, B.; Verdin, E.; Goldsmith, M.A.; Keppler, O.T. Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1. J. Virol. 2005, 79, 5220-5226.
26. Verani, A.; Pesenti, E.; Polo, S.; Tresoldi, E.; Scarlatti, G.; Lusso, P.; Siccardi, A.G.; Vercelli, D. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J. Immunol. 1998, 161, 2084-2088.
27. Tuttle, D.L.; Anders, C.B.; Aquino-De Jesus, M.J.; Poole, P.P.; Lamers, S.L.; Briggs, D.R.; Pomeroy, S.M.; Alexander, L.; Peden, K.W.; Andiman, W.A. et al. Increased replication of nonsyncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children. AIDS Res. Hum. Retrovir. 2002, 18, 353-362.
28. Li, S.; Juarez, J.; Alali, M.; Dwyer, D.; Collman, R.; Cunningham, A.; Naif, H.M. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 1999, 73, 9741-9755.
29. Gorry, P.R.; Sterjovski, J.; Churchill, M.; Witlox, K.; Gray, L.; Cunningham, A.; Wesselingh, S. The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression. Sex Health 2004, 1, 23-34.
30. Kuroda, M.J. Macrophages: Do they impact AIDS progression more than CD4 T cells? J. Leukoc. Biol. 2010, 87, 569-573.
31. Richards, K.H.; Aasa-Chapman, M.M.; McKnight, A.; Clapham, P.R. Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies. Retrovirology 2010, 7, 48.
32. Masciotra, S.; Owen, S.M.; Rudolph, D.; Yang, C.; Wang, B.; Saksena, N.; Spira, T.; Dhawan, S.; Lal, R.B. Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression. AIDS 2002, 16, 1887-1898.
33. Etemad, B.; Fellows, A.; Kwambana, B.; Kamat, A.; Feng, Y.; Lee, S.; Sagar, M. Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection. J. Virol. 2009, 83, 9694-9708.
34. Brenchley, J.M.; Price, D.A.; Douek, D.C. HIV disease: Fallout from a mucosal catastrophe? Nat. Immunol. 2006, 7, 235-239.
35. Hasegawa, A.; Liu, H.; Ling, B.; Borda, J.T.; Alvarez, X.; Sugimoto, C.; Vinet-Oliphant, H.; Kim, W.K.; Williams, K.C.; Ribeiro, R.M. et al. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 2009, 114, 2917-2925.
36. Burdo, T.H.; Soulas, C.; Orzechowski, K.; Button, J.; Krishnan, A.; Sugimoto, C.; Alvarez, X.; Kuroda, M.J.; Williams, K.C. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog. 2010, 6, e1000842.
37. Herbein, G.; Varin, A. The macrophage in HIV-1 infection: From activation to deactivation? Retrovirology 2010, 7, 33.
38. Wallet, M.A.; Rodriguez, C.A.; Yin, L.; Saporta, S.; Chinratanapisit, S.; Hou, W.; Sleasman, J.W.; Goodenow, M.M. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 2010, 24, 1281-1290.
39. Saez-Cirion, A.; Hamimi, C.; Bergamaschi, A.; David, A.; Versmisse, P.; Melard, A.; Boufassa, F.; Barre-Sinoussi, F.; Lambotte, O.; Rouzioux, C. et al. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood 2011, 118, 955-964.
40. Zhu, T.; Mo, H.; Wang, N.; Nam, D.S.; Cao, Y.; Koup, R.A.; Ho, D.D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261, 1179-1181.
41. van't Wout, A.B.; Kootstra, N.A.; Mulder-Kampinga, G.A.; Albrecht-van Lent, N.; Scherpbier, H.J.; Veenstra, J.; Boer, K.; Coutinho, R.A.; Miedema, F.; Schuitemaker, H. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 1994, 94, 2060-2067.
42. Margolis, L.; Shattock, R. Selective transmission of CCR5-utilizing HIV-1: The 'gatekeeper' problem resolved? Nat. Rev. Microbiol. 2006, 4, 312-317.
43. Haase, A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464, 217-223.
44. Nawaz, F.; Cicala, C.; Van Ryk, D.; Block, K.E.; Jelicic, K.; McNally, J.P.; Ogundare, O.; Pascuccio, M.; Patel, N.; Wei, D. et al. The genotype of early-transmitting HIV gp120s promotes alpha (4) beta(7)-reactivity, revealing alpha (4) beta(7) +/CD4+ T cells as key targets in mucosal transmission. PLoS Pathog. 2011, 7, e1001301.
45. Keele, B.F.; Derdeyn, C.A. Genetic and antigenic features of the transmitted virus. Curr. Opin. HIV AIDS 2009, 4, 352-357.
46. Abrahams, M.R.; Anderson, J.A.; Giorgi, E.E.; Seoighe, C.; Mlisana, K.; Ping, L.H.; Athreya, G.S.; Treurnicht, F.K.; Keele, B.F.; Wood, N. et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J. Virol. 2009, 83, 3556-3567.
47. Salazar-Gonzalez, J.F.; Salazar, M.G.; Keele, B.F.; Learn, G.H.; Giorgi, E.E.; Li, H.; Decker, J.M.; Wang, S.; Baalwa, J.; Kraus, M.H. et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 2009, 206, 1273-1289.
48. Fischer, W.; Ganusov, V.V.; Giorgi, E.E.; Hraber, P.T.; Keele, B.F.; Leitner, T.; Han, C.S.; Gleasner, C.D.; Green, L.; Lo, C.C. et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 2010, 5, e12303.
49. Haaland, R.E.; Hawkins, P.A.; Salazar-Gonzalez, J.; Johnson, A.; Tichacek, A.; Karita, E.; Manigart, O.; Mulenga, J.; Keele, B.F.; Shaw, G.M.; et al. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. 2009, 5, e1000274.
50. Li, H.; Bar, K.J.; Wang, S.; Decker, J.M.; Chen, Y.; Sun, C.; Salazar-Gonzalez, J.F.; Salazar, M.G.; Learn, G.H.; Morgan, C.J. et al. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 2010, 6, e1000890.
51. Bar, K.J.; Li, H.; Chamberland, A.; Tremblay, C.; Routy, J.P.; Grayson, T.; Sun, C.; Wang, S.; Learn, G.H.; Morgan, C.J.; et al. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J. Virol. 2010, 84, 6241-6247.
52. Kishko, M.; Somasundaran, M.; Brewster, F.; Sullivan, J.L.; Clapham, P.R.; Luzuriaga, K. Genotypic and functional properties of early infant HIV-1 envelopes. Retrovirology 2011, 8, 67.
53. Isaacman-Beck, J.; Hermann, E.A.; Yi, Y.; Ratcliffe, S.J.; Mulenga, J.; Allen, S.; Hunter, E.; Derdeyn, C.A.; Collman, R.G. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J. Virol. 2009, 83, 8208-8220.
54. Ochsenbauer-Jambor, C.; Ding, H.; Keele, B.F.; Salazar-Gonzalez, J.; Edmonds, T.G.; Shattock, R.; Clapham, P.; Shaw, G.; Hahn, B.H.; Kappes, J.C. Generation and biological characterization of infectious molecular clones derived from clade b HIV-1 transmitted/founder viruses. In Proceedings of the 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 8-11 February 2009; Session 89, No. 492.
55. Baalwa, J.; Wang, S.; Yue, L.; Kaleebu, P.; Cormier, E.; Gilmour, J.; Hunter, E.; Haynes, B.F.; Hahn, B.H.; Shaw, G. Enhanced fusogenecity, replication kinetics, and macrophage tropism of subtype d transmitted/founder viruses in acute HIV-1 infection. In Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 27 February-2 March 2011; Session 102, No. 495.
56. Guo, J.; Wang, W.; Yu, D.; Wu, Y. Spinoculation triggers dynamic actin and cofilin activity facilitating HIV-1 infection of transformed and resting CD4 T cells. J. Virol. 2011, 85, 9824-9833.
57. Sattentau, Q. Avoiding the void: Cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 2008, 6, 815-826.
58. Ghorpade, A.; Nukuna, A.; Che, M.; Haggerty, S.; Persidsky, Y.; Carter, E.; Carhart, L.; Shafer, L.; Gendelman, H.E. Human immunodeficiency virus neurotropism: An analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J. Virol. 1998, 72, 3340-3350.
59. Gorry, P.R.; Bristol, G.; Zack, J.A.; Ritola, K.; Swanstrom, R.; Birch, C.J.; Bell, J.E.; Bannert, N.; Crawford, K.; Wang, H. et al. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J. Virol. 2001, 75, 10073-10089.
60. Smit, T.K.; Wang, B.; Ng, T.; Osborne, R.; Brew, B.; Saksena, N.K. Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): Evidence for neurotropic HIV variants. Virology 2001, 279, 509-526.
61. Peters, P.J.; Bhattacharya, J.; Hibbitts, S.; Dittmar, M.T.; Simmons, G.; Bell, J.; Simmonds, P.; Clapham, P.R. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J. Virol. 2004, 78, 6915-6926.
62. Dunfee, R.L.; Thomas, E.R.; Gorry, P.R.; Wang, J.; Taylor, J.; Kunstman, K.; Wolinsky, S.M.; Gabuzda, D. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 15160-15165.
63. Dunfee, R.L.; Thomas, E.R.; Wang, J.; Kunstman, K.; Wolinsky, S.M.; Gabuzda, D. Loss of the n-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. Virology 2007, 367, 222-234.
64. Peters, P.J.; Duenas-Decamp, M.J.; Sullivan, W.M.; Clapham, P.R. Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues. J. Neuroimmune Pharmacol. 2007, 2, 32-41.
65. Thomas, E.R.; Dunfee, R.L.; Stanton, J.; Bogdan, D.; Taylor, J.; Kunstman, K.; Bell, J.E.; Wolinsky, S.M.; Gabuzda, D. Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology 2007, 360, 105-119.
66. Rossi, F.; Querido, B.; Nimmagadda, M.; Cocklin, S.; Navas-Martin, S.; Martin-Garcia, J. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors. Retrovirology 2008, 5, 89.
67. Dunfee, R.L.; Thomas, E.R.; Gabuzda, D. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12. Retrovirology 2009, 6, 69.
68. Gray, L.; Roche, M.; Churchill, M.J.; Sterjovski, J.; Ellett, A.; Poumbourios, P.; Sherieff, S.; Wang, B.; Saksena, N.; Purcell, D.F. et al. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dualtropic virus in the brain. J. Virol. 2009, 83, 5430-5441.
69. van Marle, G.; Gill, M.J.; Kolodka, D.; McManus, L.; Grant, T.; Church, D.L. Compartmentalization of the gut viral reservoir in HIV-1 infected patients. Retrovirology 2007, 4, 87.
70. Tovanabutra, S.; de Souza, M.; Sittisombut, N.; Sriplienchan, S.; Ketsararat, V.; Birx, D.L.; Khamboonrueng, C.; Nelson, K.E.; McCutchan, F.E.; Robb, M.L. HIV-1 genetic diversity and compartmentalization in mother/infant pairs infected with CRF01_AE. AIDS 2007, 21, 1050-1053.
71. Ritola, K.; Robertson, K.; Fiscus, S.A.; Hall, C.; Swanstrom, R. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J. Virol. 2005, 79, 10830-10834.
72. Burkala, E.J.; He, J.; West, J.T.; Wood, C.; Petito, C.K. Compartmentalization of HIV-1 in the central nervous system: Role of the choroid plexus. AIDS 2005, 19, 675-684.
73. Abbate, I.; Cappiello, G.; Longo, R.; Ursitti, A.; Spano, A.; Calcaterra, S.; Dianzani, F.; Antinori, A.; Capobianchi, M.R. Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from AIDS patients with neurological disorders. Infect. Genet. Evol. 2005, 5, 247-253.
74. Kemal, K.S.; Foley, B.; Burger, H.; Anastos, K.; Minkoff, H.; Kitchen, C.; Philpott, S.M.; Gao, W.; Robison, E.; Holman, S.; et al. HIV-1 in genital tract and plasma of women: Compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 12972-12977.
75. Becquart, P.; Chomont, N.; Roques, P.; Ayouba, A.; Kazatchkine, M.D.; Belec, L.; Hocini, H. Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology 2002, 300, 109-117.
76. Marras, D.; Bruggeman, L.A.; Gao, F.; Tanji, N.; Mansukhani, M.M.; Cara, A.; Ross, M.D.; Gusella, G.L.; Benson, G.; D'Agati, V.D. et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat. Med. 2002, 8, 522-526.
77. Haddad, D.N.; Birch, C.; Middleton, T.; Dwyer, D.E.; Cunningham, A.L.; Saksena, N.K. Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells. AIDS 2000, 14, 2273-2281.
78. Coombs, R.W.; Speck, C.E.; Hughes, J.P.; Lee, W.; Sampoleo, R.; Ross, S.O.; Dragavon, J.; Peterson, G.; Hooton, T.M.; Collier, A.C. et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood. J. Infect. Dis. 1998, 177, 320-330.
79. Fulcher, J.A.; Hwangbo, Y.; Zioni, R.; Nickle, D.; Lin, X.; Heath, L.; Mullins, J.I.; Corey, L.; Zhu, T. Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection. J. Virol. 2004, 78, 7883-7893.
80. Potter, S.J.; Lemey, P.; Achaz, G.; Chew, C.B.; Vandamme, A.M.; Dwyer, D.E.; Saksena, N.K. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J. Leukoc. Biol. 2004, 76, 562-570.
81. Llewellyn, N.; Zioni, R.; Zhu, H.; Andrus, T.; Xu, Y.; Corey, L.; Zhu, T. Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: Genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy. J. Leukoc. Biol. 2006, 80, 1118-1126.
82. Bull, M.; Learn, G.; Genowati, I.; McKernan, J.; Hitti, J.; Lockhart, D.; Tapia, K.; Holte, S.; Dragavon, J.; Coombs, R. et al. Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations. PLoS One 2009, 4, e7122.
83. Bull, M.E.; Learn, G.H.; McElhone, S.; Hitti, J.; Lockhart, D.; Holte, S.; Dragavon, J.; Coombs, R.W.; Mullins, J.I.; Frenkel, L.M. Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus. J. Virol. 2009, 83, 6020-6028.
84. Anderson, J.A.; Ping, L.H.; Dibben, O.; Jabara, C.B.; Arney, L.; Kincer, L.; Tang, Y.; Hobbs, M.; Hoffman, I.; Kazembe, P.; et al. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog. 2010, 6, e1001053.
85. Gantt, S.; Carlsson, J.; Heath, L.; Bull, M.E.; Shetty, A.K.; Mutsvangwa, J.; Musingwini, G.; Woelk, G.; Zijenah, L.S.; Katzenstein, D.A. et al. Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J. Virol. 2010, 84, 10812-10819.
86. Salazar-Gonzalez, J.F.; Salazar, M.G.; Learn, G.H.; Fouda, G.G.; Kang, H.H.; Mahlokozera, T.; Wilks, A.B.; Lovingood, R.V.; Stacey, A.; Kalilani, L. et al. Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing. J. Virol. 2011, 85, 2751-2763.
87. Massari, F.E.; Poli, G.; Schnittman, S.M.; Psallidopoulos, M.C.; Davey, V.; Fauci, A.S. In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. J. Immunol. 1990, 144, 4628-4632.
88. Xu, Y.; Zhu, H.; Wilcox, C.K.; van't Wout, A.; Andrus, T.; Llewellyn, N.; Stamatatos, L.; Mullins, J.I.; Corey, L.; Zhu, T. Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus. J. Infect. Dis. 2008, 197, 309-318.
89. Harrington, P.R.; Schnell, G.; Letendre, S.L.; Ritola, K.; Robertson, K.; Hall, C.; Burch, C.L.; Jabara, C.B.; Moore, D.T.; Ellis, R.J. et al. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 2009, 23, 907-915.
90. Schnell, G.; Price, R.W.; Swanstrom, R.; Spudich, S. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J. Virol. 2010, 84, 2395-2407.
91. Kosakovsky Pond, S.L.; Poon, A.F.; Zarate, S.; Smith, D.M.; Little, S.J.; Pillai, S.K.; Ellis, R.J.; Wong, J.K.; Leigh Brown, A.J.; Richman, D.D. et al. Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Stat. Med. 2008, 27, 4779-4789.
92. Collini, P.; Noursadeghi, M.; Sabroe, I.; Miller, R.F.; Dockrell, D.H. Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity. Curr. Mol. Med. 2010, 10, 727-740.
93. Shen, R.; Richter, H.E.; Clements, R.H.; Novak, L.; Huff, K.; Bimczok, D.; Sankaran-Walters, S.; Dandekar, S.; Clapham, P.R.; Smythies, L.E.; et al. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J. Virol. 2009, 83, 3258-3267.
94. Shen, R.; Meng, G.; Ochsenbauer, C.; Clapham, P.R.; Grams, J.; Novak, L.; Kappes, J.C.; Smythies, L.E.; Smith, P.D. Stromal down-regulation of macrophage CD4/CCR5 expression and NF-kappaB activation mediates HIV-1 non-permissiveness in intestinal macrophages. PLoS Pathog. 2011, 7, e1002060.
95. He, J.; Chen, Y.; Farzan, M.; Choe, H.; Ohagen, A.; Gartner, S.; Busciglio, J.; Yang, X.; Hofmann, W.; Newman, W. et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997, 385, 645-649.
96. Aasa-Chapman, M.M.; Seymour, C.R.; Williams, I.; McKnight, A. Novel envelope determinants for CCR3 use by human immunodeficiency virus. J. Virol. 2006, 80, 10884-10889.
97. Borderia, A.V.; Codoner, F.M.; Sanjuan, R. Selection promotes organ compartmentalization in HIV-1: Evidence from gag and pol genes. Evolution 2007, 61, 272-279.
98. Wodarz, D.; Levy, D.N. Effect of different modes of viral spread on the dynamics of multiply infected cells in human immunodeficiency virus infection. J. R. Soc. Interface 2011, 8, 289-300.
99. Levy, D.N.; Aldrovandi, G.M.; Kutsch, O.; Shaw, G.M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 4204-4209.
100. Chen, J.; Rhodes, T.D.; Hu, W.S. Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells. J. Virol. 2005, 79, 9337-9340.
101. Brown, R.J.; Peters, P.J.; Caron, C.; Gonzalez-Perez, M.P.; Stones, L.; Ankghuambom, C.; Pondei, K.; McClure, C.P.; Alemnji, G.; Taylor, S. et al. Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors. J. Virol. 2011, 85, 6024-6037.
102. Sigal, A.; Kim, J.T.; Balazs, A.B.; Dekel, E.; Mayo, A.; Milo, R.; Baltimore, D. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 2011, 477, 95-98.
103. Del Portillo, A.; Tripodi, J.; Najfeld, V.; Wodarz, D.; Levy, D.N.; Chen, B.K. Multiploid inheritance of HIV-1 during cell-to-cell infection. J. Virol. 2011, 85, 7169-7176.
104. Lamers, S.L.; Gray, R.R.; Salemi, M.; Huysentruyt, L.C.; McGrath, M.S. HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect. Genet. Evol. 2011, 11, 31-37.
105. Peters, P.J.; Duenas-Decamp, M.J.; Sullivan, W.M.; Brown, R.; Ankghuambom, C.; Luzuriaga, K.; Robinson, J.; Burton, D.R.; Bell, J.; Simmonds, P. et al. Variation in HIV-1 R5 macrophagetropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology 2008, 5, 5.
106. Duenas-Decamp, M.J.; Peters, P.J.; Burton, D.; Clapham, P.R. Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes. J. Virol. 2009, 83, 2575-2583.
107. Dunfee, R.L.; Thomas, E.R.; Gorry, P.R.; Wang, J.; Taylor, J.; Kunstman, K.; Wolinsky, S.M.; Gabuzda, D. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 15160-15165.
108. Duenas-Decamp, M.J.; Peters, P.; Burton, D.; Clapham, P.R. Natural resistance of human immunodeficiency virus type 1 to the CD4BS antibody B12 conferred by a glycan and an arginine residue close to the CD4 binding loop. J. Virol. 2008, 82, 5807-5814.
109. Musich, T.; Peters, P.J.; Duenas-Decamp, M.J.; Gonzalez-Perez, M.P.; Robinson, J.; Zolla-Pazner, S.; Ball, J.K.; Luzuriaga, K.; Clapham, P.R. A conserved determinant in the V1 loop of HIV-1 that modulates the V3 loop to prime low CD4 use and macrophage infection. J. Virol. 2011, 85, 2397-2405.
110. Sterjovski, J.; Roche, M.; Churchill, M.J.; Ellett, A.; Farrugia, W.; Gray, L.R.; Cowley, D.; Poumbourios, P.; Lee, B.; Wesselingh, S.L. et al. An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes. Virology 2010, 404, 269-278.
111. Gray, L.; Roche, M.; Churchill, M.J.; Sterjovski, J.; Ellett, A.; Poumbourios, P.; Sherieff, S.; Wang, B.; Saksena, N.; Purcell, D.F. et al. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain. J. Virol. 2009, 83, 5430-5441.
112. Cashin, K.; Roche, M.; Sterjovski, J.; Ellett, A.; Gray, L.R.; Cunningham, A.L.; Ramsland, P.A.; Churchill, M.J.; Gorry, P.R. Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages. J. Virol. 2011, 85, 10699-10709.
113. Bannert, N.; Kurth, R. Retroelements and the human genome: New perspectives on an old relation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 14572-14579.
114. Kirchhoff, F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 2010, 8, 55-67.
115. Malim, M.H.; Emerman, M. HIV-1 accessory proteins--ensuring viral survival in a hostile environment. Cell Host Microbe 2008, 3, 388-398.
116. Dayton, A.I.; Sodroski, J.G.; Rosen, C.A.; Goh, W.C.; Haseltine, W.A. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 1986, 44, 941-947.
117. Sonza, S.; Mutimer, H.P.; O'Brien, K.; Ellery, P.; Howard, J.L.; Axelrod, J.H.; Deacon, N.J.; Crowe, S.M.; Purcell, D.F. Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages. J. Virol. 2002, 76, 12611-12621.
118. Dowling, D.; Nasr-Esfahani, S.; Tan, C.H.; O'Brien, K.; Howard, J.L.; Jans, D.A.; Purcell, D.F.; Stoltzfus, C.M.; Sonza, S. HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages. Retrovirology 2008, 5, 18.
119. Neuveut, C.; Scoggins, R.M.; Camerini, D.; Markham, R.B.; Jeang, K.T. Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1. J. Biomed. Sci. 2003, 10, 651-660.
120. Hiebenthal-Millow, K.; Greenough, T.C.; Bretttler, D.B.; Schindler, M.; Wildum, S.; Sullivan, J.L.; Kirchhoff, F. Alterations in HIV-1 LTR promoter activity during AIDS progression. Virology 2003, 317, 109-118.
121. Cowley, D.; Gray, L.R.; Wesselingh, S.L.; Gorry, P.R.; Churchill, M.J. Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia. J. Neurovirol. 2011, 17, 70-81.
122. Zhang, M.; Drenkow, J.; Lankford, C.S.; Frucht, D.M.; Rabin, R.L.; Gingeras, T.R.; Venkateshan, C.; Schwartzkopff, F.; Clouse, K.A.; Dayton, A.I. HIV regulation of the IL-7R: A viral mechanism for enhancing HIV-1 replication in human macrophages in vitro. J. Leukoc. Biol. 2006, 79, 1328-1338.
123. Gabuzda, D.H.; Li, H.; Lawrence, K.; Vasir, B.S.; Crawford, K.; Langhoff, E. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J. Acquir. Immune Defic. Syndr. 1994, 7, 908-915.
124. Kawamura, M.; Ishizaki, T.; Ishimoto, A.; Shioda, T.; Kitamura, T.; Adachi, A. Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J. Gen. Virol. 1994, 75, 2427-2431.
125. Chowdhury, I.H.; Chao, W.; Potash, M.J.; Sova, P.; Gendelman, H.E.; Volsky, D.J. Vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J. Virol. 1996, 70, 5336-5345.
126. Sheehy, A.M.; Gaddis, N.C.; Choi, J.D.; Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral vif protein. Nature 2002, 418, 646-650.
127. Malim, M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364, 675-687.
128. Miyagi, E.; Schwartzkopff, F.; Plishka, R.; Buckler-White, A.; Clouse, K.A.; Strebel, K. APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages. Virology 2008, 379, 266-274.
129. Deacon, N.J.; Tsykin, A.; Solomon, A.; Smith, K.; Ludford-Menting, M.; Hooker, D.J.; McPhee, D.A.; Greenway, A.L.; Ellett, A.; Chatfield, C. et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270, 988-991.
130. Kestler, H.W., 3rd; Ringler, D.J.; Mori, K.; Panicali, D.L.; Sehgal, P.K.; Daniel, M.D.; Desrosiers, R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65, 651-662.
131. Kirchhoff, F.; Greenough, T.C.; Brettler, D.B.; Sullivan, J.L.; Desrosiers, R.C. Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New Engl. J. Med. 1995, 332, 228-232.
132. Malykh, A.; Reitz, M.S., Jr.; Louie, A.; Hall, L.; Lori, F. Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages. Virology 1995, 206, 646-650.
133. Miller, M.D.; Warmerdam, M.T.; Gaston, I.; Greene, W.C.; Feinberg, M.B. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 1994, 179, 101-113.
134. Learmont, J.; Tindall, B.; Evans, L.; Cunningham, A.; Cunningham, P.; Wells, J.; Penny, R.; Kaldor, J.; Cooper, D.A. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992, 340, 863-867.
135. Gorry, P.R.; McPhee, D.A.; Wesselingh, S.L.; Churchill, M.J. Macrophage tropism and cytopathicity of HIV-1 variants isolated sequentially from a long-term survivor infected with nefdeleted virus. Open Microbiol. J. 2007, 1, 1-7.
136. Brown, A.; Moghaddam, S.; Kawano, T.; Cheng-Mayer, C. Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages. J. Gen. Virol. 2004, 85, 1463-1469.
137. Goldsmith, M.A.; Warmerdam, M.T.; Atchison, R.E.; Miller, M.D.; Greene, W.C. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 nef. J. Virol. 1995, 69, 4112-4121.
138. Lundquist, C.A.; Tobiume, M.; Zhou, J.; Unutmaz, D.; Aiken, C. Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J. Virol. 2002, 76, 4625-4633.
139. Glushakova, S.; Munch, J.; Carl, S.; Greenough, T.C.; Sullivan, J.L.; Margolis, L.; Kirchhoff, F. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo. J. Virol. 2001, 75, 10113-10117.
140. Cortes, M.J.; Wong-Staal, F.; Lama, J. Cell surface CD4 interferes with the infectivity of HIV-1 particles released from T cells. J. Biol. Chem. 2002, 277, 1770-1779.
141. Ross, T.M.; Oran, A.E.; Cullen, B.R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 1999, 9, 613-621.
142. Lama, J.; Mangasarian, A.; Trono, D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 1999, 9, 622-631.
143. Bennett, A.E.; Narayan, K.; Shi, D.; Hartnell, L.M.; Gousset, K.; He, H.; Lowekamp, B.C.; Yoo, T.S.; Bliss, D.; Freed, E.O.; et al. Ion-abrasion scanning electron microscopy reveals surfaceconnected tubular conduits in HIV-infected macrophages. PLoS Pathog. 2009, 5, e1000591.
144. Welsch, S.; Groot, F.; Krausslich, H.G.; Keppler, O.T.; Sattentau, Q.J. Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J. Virol. 2011, 85, 7922-7927.
145. Welsch, S.; Keppler, O.T.; Habermann, A.; Allespach, I.; Krijnse-Locker, J.; Krausslich, H.G. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 2007, 3, e36.
146. Gray, L.R.; Gabuzda, D.; Cowley, D.; Ellett, A.; Chiavaroli, L.; Wesselingh, S.L.; Churchill, M.J.; Gorry, P.R. CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates. J. Neurovirol. 2011, 17, 82-91.
147. Pushker, R.; Jacque, J.M.; Shields, D.C. Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression. J. Virol. 2010, 84, 3644-3653.
148. Neil, S.J.; Zang, T.; Bieniasz, P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451, 425-430.
149. Van Damme, N.; Goff, D.; Katsura, C.; Jorgenson, R.L.; Mitchell, R.; Johnson, M.C.; Stephens, E.B.; Guatelli, J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3, 245-252.
150. Schubert, U.; Clouse, K.A.; Strebel, K. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 1995, 69, 7699-7711.
151. Schindler, M.; Rajan, D.; Banning, C.; Wimmer, P.; Koppensteiner, H.; Iwanski, A.; Specht, A.; Sauter, D.; Dobner, T.; Kirchhoff, F. Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology 2010, 7, 1.
152. Schubert, U.; Bour, S.; Willey, R.L.; Strebel, K. Regulation of virus release by the macrophagetropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either vpu or env. J. Virol. 1999, 73, 887-896.
153. Richards, K.H.; Clapham, P.R. Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages. J. Gen. Virol. 2007, 88, 2780-2792.
154. Miyagi, E.; Andrew, A.J.; Kao, S.; Strebel, K. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 2868-2873.
155. Ayinde, D.; Maudet, C.; Transy, C.; Margottin-Goguet, F. Limelight on two HIV/SIV accessory proteins in macrophage infection: Is Vpx overshadowing Vpr? Retrovirology 2010, 7, 35.
156. Sunseri, N.; O'Brien, M.; Bhardwaj, N.; Landau, N.R. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J. Virol. 2011, 85, 6263-6274.
157. Kaushik, R.; Zhu, X.; Stranska, R.; Wu, Y.; Stevenson, M. A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 2009, 6, 68-80.
158. Hrecka, K.; Hao, C.; Gierszewska, M.; Swanson, S.K.; Kesik-Brodacka, M.; Srivastava, S.; Florens, L.; Washburn, M.P.; Skowronski, J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474, 658-661.
159. Laguette, N.; Sobhian, B.; Casartelli, N.; Ringeard, M.; Chable-Bessia, C.; Segeral, E.; Yatim, A.; Emiliani, S.; Schwartz, O.; Benkirane, M. Samhd1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474, 654-657.
160. Yan, N.; Regalado-Magdos, A.D.; Stiggelbout, B.; Lee-Kirsch, M.A.; Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 2010, 11, 1005-1013.